These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 17020421

  • 1. Nadifloxacin: a quinolone for topical treatment of skin infections and potential for systemic use of its active isomer, WCK 771.
    Jacobs MR, Appelbaum PC.
    Expert Opin Pharmacother; 2006 Oct; 7(14):1957-66. PubMed ID: 17020421
    [Abstract] [Full Text] [Related]

  • 2. Topical nadifloxacin 1% cream vs. topical erythromycin 4% gel in the treatment of mild to moderate acne.
    Tunca M, Akar A, Ozmen I, Erbil H.
    Int J Dermatol; 2010 Dec; 49(12):1440-4. PubMed ID: 21091683
    [Abstract] [Full Text] [Related]

  • 3. Lack of irritative potential of nadifloxacin 1% when combined with other topical anti-acne agents.
    Wilhelm KP, Wilhelm D, Neumeister C, Zsolt I, Schwantes U.
    Clin Exp Dermatol; 2012 Mar; 37(2):112-7. PubMed ID: 22103435
    [Abstract] [Full Text] [Related]

  • 4. Clinical and bacteriological evaluation of nadifloxacin 1% cream in patients with acne vulgaris: a double-blind, phase III comparison study versus erythromycin 2% cream.
    Plewig G, Holland KT, Nenoff P.
    Eur J Dermatol; 2006 Mar; 16(1):48-55. PubMed ID: 16436342
    [Abstract] [Full Text] [Related]

  • 5. Clinical and histological evaluation of 1% nadifloxacin cream in the treatment of acne vulgaris in Korean patients.
    Jung JY, Kwon HH, Yeom KB, Yoon MY, Suh DH.
    Int J Dermatol; 2011 Mar; 50(3):350-7. PubMed ID: 21342170
    [Abstract] [Full Text] [Related]

  • 6. Direct analysis of resistance in the cutaneous microflora during treatment of acne vulgaris with topical 1% nadifloxacin and 2% erythromycin.
    Bojar RA, Hittel N, Cunliffe WJ, Holland KT.
    Drugs; 1995 Mar; 49 Suppl 2():164-7. PubMed ID: 8549289
    [No Abstract] [Full Text] [Related]

  • 7. Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes.
    Kuwahara K, Kitazawa T, Kitagaki H, Tsukamoto T, Kikuchi M.
    J Dermatol Sci; 2005 Apr; 38(1):47-55. PubMed ID: 15795123
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antimicrobial evaluation of nadifloxacin (OPC-7251), a new topical quinolone, in acne vulgaris.
    Vogt K, Hahn H, Hermann J, Haustein UF, Blume U, Gollnick H, Orfanos CE.
    Drugs; 1995 Apr; 49 Suppl 2():266-8. PubMed ID: 8549327
    [No Abstract] [Full Text] [Related]

  • 11. Levonadifloxacin arginine salt to treat acute bacterial skin and skin structure infection due to S. aureus including MRSA.
    Saxena D, Kaul G, Dasgupta A, Chopra S.
    Drugs Today (Barc); 2020 Sep; 56(9):583-598. PubMed ID: 33025952
    [Abstract] [Full Text] [Related]

  • 12. [Effect of longidase ultraphonophoresis on skin microbiocenosis in patients with acne].
    Vasil'eva ES.
    Vopr Kurortol Fizioter Lech Fiz Kult; 2008 Sep; (6):32-4. PubMed ID: 19177663
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A primer on topical antibiotics for the skin and eyes.
    Noah S.
    J Drugs Dermatol; 2008 Apr; 7(4):409-15. PubMed ID: 18459527
    [Abstract] [Full Text] [Related]

  • 15. Dapsone 5% gel: a review of its efficacy and safety in the treatment of acne vulgaris.
    Stotland M, Shalita AR, Kissling RF.
    Am J Clin Dermatol; 2009 Apr; 10(4):221-7. PubMed ID: 19489655
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The assessment of bacterial flora and antibiotic-sensitivity of bacteria isolated from conjunctival sac, skin of the eyelids and inflammatory lesions in patients with acne vulgaris and rosacea].
    Kaszuba-Bartkowiak K, Goś R.
    Przegl Lek; 2007 Apr; 64(12):991-6. PubMed ID: 18595500
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of nadifloxacin against several Gram-positive bacteria and analysis of the possible evolution of resistance after 2 years of use in Germany.
    Alba V, Urban E, Angeles Dominguez M, Nagy E, Nord CE, Palacín C, Vila J.
    Int J Antimicrob Agents; 2009 Mar; 33(3):272-5. PubMed ID: 19095414
    [Abstract] [Full Text] [Related]

  • 20. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study.
    Marcinkiewicz J, Wojas-Pelc A, Walczewska M, Lipko-Godlewska S, Jachowicz R, Maciejewska A, Białecka A, Kasprowicz A.
    Eur J Dermatol; 2008 Mar; 18(4):433-9. PubMed ID: 18573718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.